Trial · NCT03202979
Trazodone in Painful Diabetic Neuropathy
NCT03202979, Phase 2, Completed, Aziende Chimiche Riunite Angelini Francesco S.p.A
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Trazodone in Painful Diabetic Neuropathy. Trials, record NCT03202979. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03202979
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Trazodone in Painful Diabetic Neuropathy
- NCT number
- NCT03202979
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 142 participants, actual
- Lead sponsor
- Aziende Chimiche Riunite Angelini Francesco S.p.A
- Conditions
- Painful Diabetic Neuropathy
- Interventions
- Trazodone 20 mg, Trazodone 10 mg, Placebo
- First posted
- 2017-06-29
- Last updated
- 2018-09-28
- Other registries' IDs
- eudract:2016-002772-27
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change of item 5 score in Brief Pain Inventory Short Form (BPI-SF) scale | Baseline - Day 56 | Change from baseline of item 5 score in BPI-SF numering scale after 56 days. |
| Secondary | Change of item 5 score in Brief Pain Inventory Short Form (BPI-SF) scale | Baseline - Days 7, 14, 21, 28, 35, 42, 49, 63 | Change from baseline of item 5 score in BPI-SF numering scale after 7, 14, 21, 28, 35, 42, 49 and 63 days. |
| Secondary | Change of item 3 score in Brief Pain Inventory Short Form (BPI-SF) scale | Baseline - Days 7, 14, 21, 28, 35, 42, 49, 56 and 63. | Change from baseline of item 3 score in BPI-SF numering scale after 7, 14, 21, 28, 35, 42, 49, 56 and 63 days. |
| Secondary | Change of item 4 score in Brief Pain Inventory Short Form (BPI-SF) scale | Baseline - Days 7, 14, 21, 28, 35, 42, 49, 56 and 63. | Change from baseline of item 4 score in BPI-SF numering scale after 7, 14, 21, 28, 35, 42, 49, 56 and 63 days. |
| Secondary | Change of item 5 score in Brief Pain Inventory Short Form (BPI-SF) scale | Baseline - Days 7, 14, 21, 28, 35, 42, 49, 56 and 63. | Change from baseline of item 5 score in BPI-SF numering scale after 7, 14, 21, 28, 35, 42, 49, 56 and 63 days. |
| Secondary | Change of item 6 score in Brief Pain Inventory Short Form (BPI-SF) scale | Baseline - Days 7, 14, 21, 28, 35, 42, 49, 56 and 63. | Change from baseline of item 6 score in BPI-SF numering scale after 7, 14, 21, 28, 35, 42, 49, 56 and 63 days. |
| Secondary | Change of item 8 score in Brief Pain Inventory Short Form (BPI-SF) scale | Baseline - Days 7, 14, 21, 28, 35, 42, 49, 56 and 63. | Change from baseline of item 8 score in BPI-SF numering scale after 7, 14, 21, 28, 35, 42, 49, 56 and 63 days. |
| Secondary | Change of item 9 score in Brief Pain Inventory Short Form (BPI-SF) scale | Baseline - Days 7, 14, 21, 28, 35, 42, 49, 56 and 63. | Change from baseline of item 9 score in BPI-SF numering scale after 7, 14, 21, 28, 35, 42, 49, 56 and 63 days. |
| Secondary | Change in Neuropathic Pain Symptom Inventory (NPSI) scale | Baseline - Days 7, 14, 21, 28, 35, 42, 49, 56 and 63. | Change from baseline of total score in NPSI scale after 7, 14, 21, 28, 35, 42, 49, 56 and 63 days. |
| Secondary | Change in 36-item Short-Form Health Survey (SF-36) | Baseline - Day 56 | Change from baseline of SF-36 after 56 days. |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 32936427 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03202979
GET https://conductscience.org/api/trials/v1/NCT03202979/registered